NB110-57057 17-beta-HSD1 / HSD17B1 (C-term) antibody

See related secondary antibodies

Search for all "17-beta-HSD1 / HSD17B1"

0.1 ml / €430.00
Delivery Time: 5-7 workingdays

Quick Overview

Rabbit anti Human 17-beta-HSD1 / HSD17B1 EP1682Y

NB110-57057

More Views

  • NB110-57057

Product Description for 17-beta-HSD1 / HSD17B1

Rabbit anti Human 17-beta-HSD1 / HSD17B1 EP1682Y.
Properties: (C-term)
Presentation: Purified
Product is tested for Flow Cytometry, Immunocytochemistry/Immunofluorescence, Paraffin Sections, Immunoprecipitation, Western blot / Immunoblot.

Properties for 17-beta-HSD1 / HSD17B1

Product Category Antibodies
Quantity 0.1 ml
Synonyms 17-beta-hydroxysteroid dehydrogenase type 1, 17E2DH, 20 alpha-hydroxysteroid dehydrogenase, 20-alpha HSD, E17KSR, EDH17B1, EDH17B2, EDHB17, Estradiol 17-beta-dehydrogenase 1, Placental 17-beta-hydroxysteroid dehydrogenase
Presentation Purified
Reactivity Hu
Applications F, ICC/IF, IP, P, WB
Clonality Monoclonal
Clone EP1682Y
Host Rabbit
Isotype IgG
Shipping to Not USA/Canada
PDF datasheet View Datasheet
Manufacturer Novus Biologicals Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
P14061
Genename:
3292
Property C-term
Antibody type Ab
Add. information Research Areas: Cancer
Application flow cytometry / FACS analysis, Immunocytochemistry, immunohistochemistry, immunoprecipitation, Western Blot, Flow cytometry / FACS analysis, Immunohistochemistry, Immunoprecipitation, Western Blot and Immunocytochemistry, flow cytometry / FACS analysis 1:15, immunohistochemistry 1:100 ? 250, immunoprecipitation 1:100, Western Blot 1:100000, Immunocytochemistry 1:100 ? 250
Background The principal human estrogen, 17 beta-estradiol, is a potent stimulator of certain endocrine-dependent forms of breast cancer. Because human estrogenic 17 beta-hydroxysteroid dehydrogenase (HSD17B1) catalyzes the last step in the biosynthesis of 17 beta-estradiol from the less potent estrogen, estrone, it is an attractive target for the design of inhibitors of estrogen production and tumor growth (1). It is concluded that the steroid-binding site of human placental HSD17B1 contains a histidine residue which proximates the upper A-ring region of the steroid as it undergoes the reversible binding step (2). Human estrogenic HSD17B1 is an NADP(H)-preferring enzyme. It possesses 11- and 4-fold higher specificity toward NADP(H) over NAD(H) for oxidation and reduction, respectively, as demonstrated by kinetic studies (3). Defects in the conversion of androstenedione to testosterone in the fetal testes by the enzyme HSD17B1 give rise to genetic males with female external genitalia (4)
General Readings
  • Murdock GL, et al. J Biol Chem 258(19):11460-4, 1983.
  • Ghosh D, et al. Structure 3(5):503-13, 1995.
  • Huang YW, et al. Mol Endocrinol 15(11):2010-20, 2001
  • Geissler WM, et al. Nat Genet 7(1):34-9, 1994.
Storage Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Format
Buffer System:
0.01% Sodium Azide
State:
Purified
Specificity
Specificity:
A synthetic peptide corresponding to residues on the C-terminus of human HSD17B1 was used as an immunogen.
Species:
Human, Mouse (-), Rat (-)
Gene ID 3292
Targets

Accessory Products

Proteins and/or Positive Controls

Proteins for 17-beta-HSD1 / HSD17B1 (2 products)

Catalog No. Species Pres. Purity   Source  
H00003292-Q01-10

17-beta-HSD1 / HSD17B1

17-beta-HSD1 / HSD17B1 Human in vitro transl.
10 µg / €350.00
  Abnova Taiwan Corp.
H00003292-Q01-25

17-beta-HSD1 / HSD17B1

17-beta-HSD1 / HSD17B1 Human in vitro transl.
25 µg / €500.00
  Abnova Taiwan Corp.